• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    COMPASS Pathways Plc - American Depository Shares (NQ: CMPS )

    6.320 -0.110 (-1.71%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Jun 20, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 422,146
    Open 6.410
    Bid (Size) 6.300 (5)
    Ask (Size) 6.600 (9)
    Prev. Close 6.430
    Today's Range 6.230 - 6.430
    52wk Range 5.010 - 12.75
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Should You Buy the Dip on Compass Pathways Stock?
    Nothing is going wrong, but one of its peers just hit a serious snag. 
    Via The Motley Fool
    Psychedelics Stocks Are Falling After a Shocking Vote at the FDA. Here's What You Need to Know.
    Regulators were not impressed by one company's petition for approval. 
    Via The Motley Fool
    Exposures Product Safety

    Performance

    YTD
    -29.70%
    -29.70%
    1 Month
    -19.70%
    -19.70%
    3 Month
    -33.47%
    -33.47%
    6 Month
    -21.20%
    -21.20%
    1 Year
    -24.22%
    -24.22%

    More News

    Read More
    Largest Psychedelic Compound Based Drug Stocks Fell 13% Last Week - Here's Why
    Via Talk Markets
    What's Going On With MindMed And Psychedelic Stocks?
    Via Benzinga
    DouYu International Posts Q1 Results, Joins Annexon, Dollar Tree And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
    Via Benzinga
    Why Lands' End Shares Are Trading Lower? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's Pre-Market Session
    Via Benzinga
    Why Stitch Fix Shares Are Trading Higher By 18%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    GSK, Boston Beer And Other Big Stocks Moving Lower In Monday's Pre-Market Session
    Via Benzinga
    These 2 Catalysts Could Soon Send Compass Pathways Stock Soaring
    Via The Motley Fool
    Pot Company Gets License To Open Psilocybin Service Center, The Sacred Mushroom, In Oregon
    Via Benzinga
    Topics Cannabis
    Exposures Cannabis
    Compass Pathways Plc (CMPS) Q1 2024 Earnings Call Transcript
    Via The Motley Fool
    Topics Earnings
    Exposures Financial
    CMPS Stock Earnings: Compass Pathways Misses EPS for Q1 2024
    Via InvestorPlace
    Clinical-Stage BioTech Drug Stocks Portfolio Jumped 7% In First Week Of May
    Via Talk Markets
    Jim Cramer Slams Political Blocking Of 'LSD-Derived Antidepressants,' Citing Strong Test Data 'Showing They Worked'
    Via Benzinga
    Psyched: DEA Revisits Ban On Two Psychedelics, Farewell Russell Newcombe, Podcast Episode On Kanna & More
    Via Benzinga
    Who's Who In Cannabis: Latest Executive Changes You Should Know About
    Via Benzinga
    The 10 Stocks In The Clinical-Stage BioTech Drug Stocks Index Are Down 4% YTD
    Via Talk Markets
    Topics Artificial Intelligence
    Exposures Artificial Intelligence
    Largest Psychedelic Drug Stocks Up Another 10% Last Week; Now Up 54% YTD
    Via Talk Markets
    Micron, Iris Energy, Trip.com Group And Other Big Stocks Moving Higher On Monday
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    March Recap: Largest Psychedelic Drug Stocks Up Another 5%
    Via Talk Markets
    Psychedelics Headlines: A Form Of Life, Treating Chronic Pain, Microdosing And More
    Via Benzinga
    Psyched: 5-MeO-DMT For Depression, Utah Hospitals Providing Therapy, Elon Musk And Meta's Influence
    Via Benzinga
    Atai Life Sciences Q4 And Full-Year 2023 Results: Steep Cash Drain Yet 2026 Target Remains, Update On Psychedelic Pipeline
    Via Benzinga
    Psyched: LSD, Psilocybin As Breakthrough Therapies, $14M Fed Grant For Ibogaine, Indiana's Research And More
    Via Benzinga
    Topics Economy
    Exposures Interest Rates
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.